<DOC>
	<DOC>NCT00227461</DOC>
	<brief_summary>The study investigates the possibility that levetiracetam may improve the symptoms of chronic post-stroke aphasia.</brief_summary>
	<brief_title>Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.</brief_title>
	<detailed_description>In the study, 50 post-stroke subjects with aphasia will take levetiracetam and we will evaluate their speech, language, and memory in an ABAB design.</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Aphasia</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Stroke Aphasia Can give consent Renal failure Pregnancy Other neurological condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Aphasia</keyword>
	<keyword>Stroke</keyword>
</DOC>